Eric Donnenfeld, MD

home / authors / eric-donnenfeld,-md

Articles

Novel agents in the pipeline for DED

Novel agents in the pipeline for DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Agents in the pipeline for DED

Agents in the pipeline for DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Overlapping diseases and COVID-19's impact

Overlapping diseases and COVID-19's impact

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Counseling and formulary concerns for DED therapies

Counseling and formulary concerns for DED therapies

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Challenges in the management of DED

Challenges in the management of DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Treatments for aqueous dry eye

Treatments for aqueous dry eye

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Crystal Brimer, OD, FAAO, shares some in-office procedures for dry eye and the patient resistance with high cost.

In-office procedures and patient resistance for DED treatments

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Crystal Brimer, OD, FAAO, identifies the preferred treatment options for meibomian gland dysfunction.

How to treat meibomian gland dysfunction

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Eric Donnenfeld, MD, and Marguerite McDonald, MD, discuss the role of nutritional supplements as well as antibiotics in dry eye management.

The role of nutritional supplements and antibiotics in DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Corticosteroids and Immunomodulators for the treatment of dry eye

Corticosteroids and Immunomodulators for the treatment of dry eye

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Review of artificial tears for DED

Review of artificial tears for DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
OD and MD communication for optimal care

OD and MD communication for optimal care

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
General Principles of Treatment of DED

General Principles of Treatment of DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Standard testing and assessment for DED

Standard testing and assessment for DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Diagnosis and overlooking asymptomatic patients with DED

Diagnosis and overlooking asymptomatic patients with DED

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Consequences and epidemiology of untreated dry eye

Consequences and epidemiology of untreated dry eye

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Introduction and overview

Introduction and overview

Brooke Henson, Editor;Tracy Schroeder Swartz, OD, MS, FAAO;Marguerite McDonald, MD;Eric Donnenfeld, MD;Crystal Brimer, OD, FAAO
November 18th 2020
Why comanagement matters

Why comanagement matters

Eric Donnenfeld, MD
August 4th 2020
Surgical therapy for dry eye disease

Surgical therapy for dry eye disease

Eric Donnenfeld, MD
August 4th 2020
Surgical therapy’s role in dry eye disease

Surgical therapy’s role in dry eye disease

Eric Donnenfeld, MD
August 4th 2020

Latest Updated Articles

Patient Case 1: Delaying Cataract Surgery to Prioritize Aggressive Treatment of Ocular Surface Disease, Including Demodex Blepharitis
Published: January 14th 2025 | Updated: January 20th 2025
Patient Case 1: Delaying Cataract Surgery to Prioritize Aggressive Treatment of Ocular Surface Disease, Including Demodex Blepharitis
Preoperative Ocular Surface Disease Algorithm Overview
Published: January 7th 2025 | Updated: January 20th 2025
Preoperative Ocular Surface Disease Algorithm Overview
Poll: What pipeline presbyopia treatment are you most looking forward to?
Published: October 22nd 2021 | Updated: January 20th 2025
Poll: What pipeline presbyopia treatment are you most looking forward to?
Published: February 1st 2010 | Updated: January 20th 2025
Alcon acquires rights to three Sirion products
unilateral genetic treatment for LHON with positive bilateral results - Image credit: Adobe Stock / ©ktsdesign
Published: January 3rd 2025 | Updated: January 20th 2025
RESTORE study: Unilateral genetic treatment for LHON with positive bilateral results
Doctor showing patient a diagram of the eye in her office Image credit: ©zinkevych - adobe.stock.com
Published: August 9th 2024 | Updated: January 20th 2025
A beginner’s guide to dry eye treatment integration
© 2025 MJH Life Sciences

All rights reserved.